The pandemic H30 subclone of sequence type 131 (ST131) as the leading cause of multidrug-resistant Escherichia coli infections in the United States (2011-2012)

Open Forum Infectious Diseases

Volumn 4, Issue 2, 2017, Pages

  Johnson, James R ^a   Porter, Stephen ^a   Thuras, Paul ^a   Castanheira, Mariana ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JMI LABORATORIES   (United States)

Author keywords

Antimicrobial resistance; Escherichia coli infections; Extended spectrum beta lactamases; Fluoroquinolone resistance; ST131

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; QUINOLONE DERIVATIVE; SIDEROPHORE; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; INFANT; MALE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES;

EID: 85031926179     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofx089     Document Type: Article

References (42)

1. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003;5:449-56
2. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-e20
3. Talan DA, Takhar SS, Krishnadasan A, et al. Fluoroquinolone-resistant and extended-spectrum ß-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States. Emerg Inf Dis. 2016;22:1594-603
4. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543-74
5. Price LB, Johnson JR, Aziz M, et al. The epidemic of extended-spectrum-ß-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio. 2013;4:e00377-13
6. Johnson JR, Tchesnokova V, Johnston B, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis. 2013;207:919-28
7. Peirano G, van der Bij AK, Freeman JL, et al. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum ß-lactamases: global distribution of the H30-Rx sublineage. Antimicrob Agents Chemother. 2014;58:3762-7
8. Stoesser N, Sheppard AE, Pankhurst L, et al; Modernizing Medical Microbiology Informatics Group (MMMIG). Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. MBio. 2016;7:e02162
9. Johnson JR, Davis G, Clabots C, et al. Household clustering of Escherichia coli sequence type 131 clinical and fecal isolates according to whole genome sequence analysis. Open Forum Infect Dis. 2016;3:ofw129
10. Petty NK, Ben Zakour NL, Stanton-Cook M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A. 2014;111:5694-9
11. Matsumura Y, Johnson JR, Yamamoto M, et al; Kyoto-Shiga Clinical Microbiology Study Group; Kyoto-Shiga Clinical Microbiology Study Group. CTX-M-27-and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic. J Antimicrob Chemother. 2015;70:1639-49
12. Johnson JR, Clermont O, Johnston B, et al. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol. 2014;52:1358-65
13. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin Infect Dis. 2010;51:286-94
14. Johnson JR, Urban C, Weissman SJ, et al. Molecular epidemiology of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum cephalosporinase-producing E. coli in the United States (2000-2009). Antimicrob Agents Chemother. 2012;56:2364-70
15. Colpan A, Johnston B, Porter S, et al; VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis. 2013;57:1256-65
16. Clinical and Laboratory Standards Institute. M100-S23: Performance standards for antimicrobial susceptibility testing. 23rd informational supplement document. Wayne, PA: CLSI; 2013
17. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition (M07-A9). Wayne, PA: CLSI, 2012
18. Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller L. Escherichia coli sequence type 131 H30 is the main driver of emerging extended-spectrum-ß-lactamase-producing E. coli at a tertiary care center. mSphere. 2016;1:e00314-16
19. Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5:58-65
20. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother. 2009;53:2733-9
21. Banerjee R, Strahilevitz J, Johnson JR, et al. Predictors and molecular epidemiology of community-onset extended-spectrum ß-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol. 2013;34:947-53
22. Clermont O, Christenson JK, Daubié AS, et al. Development of an allele-specific PCR for Escherichia coli B2 sub-typing, a rapid and easy to perform substitute of multilocus sequence typing. J Microbiol Methods. 2014;101:24-7
23. Johnson JR, Owens K, Sabate M, Prats G. Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J Clin Microbiol. 2004;42:3841-3
24. Johnson JR, Owens K, Manges AR, Riley LW. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol. 2004;42:2618-22
25. Matsumura Y, Yamamoto M, Nagao M, et al; Kyoto-Shiga Clinical Microbiology Study Group. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-ß-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother. 2012;67:2612-20
26. Johnson JR, Porter S, Johnston B, et al. Host characteristics and bacterial traits predict experimental virulence for Escherichia coli bloodstream isolates from patients with urosepsis. Open Forum Infect Dis. 2015;2:ofv083
27. Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol. 2005;43:6064-72
28. Johnson JR, Porter SB, Zhanel G, et al. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun. 2012;80:1554-62
29. Johnson JR, Murray AC, Gajewski A, et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother. 2003;47:2161-8
30. Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother. 2013;57:3012-20
31. Campbell I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26:3661-75
32. Banerjee R, Robicsek A, Kuskowski M, et al. Molecular epidemiology of Escherichia coli sequence type ST131 and its H30 and H30-Rx subclones among extended-spectrum beta-lactamase-positive and-negative E. coli clinical isolates from the Chicago region (2007-2010). Antimicrob Agents Chemother. 2013;57:6385-8
33. Drawz SM, Porter S, Kuskowski MA, et al. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations. Antimicrob Agents Chemother. 2015;59:5331-9
34. Salipante SJ, Roach DJ, Kitzman JO, et al. Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strains. Genome Res. 2015;25:119-28
35. Day MJ, Doumith M, Abernethy J, et al. Population structure of Escherichia coli causing bacteraemia in the UK and Ireland between 2001 and 2010. J Antimicrob Chemother. 2016;71:2139-42
36. Tchesnokova VL, Avagyan H, Rechkina E, et al. Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection. PLoS One. 2017;12:e0174132
37. Johnson JR, Thuras P, Johnston BD, et al. The pandemic H30 subclone of Escherichia coli sequence type 131 is associated with persistent infections and adverse outcomes independent from its multidrug resistance and associations with compromised hosts. Clin Infect Dis. 2016;62:1529-36
38. Mike LA, Smith SN, Sumner CA, et al. Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection. Proc Natl Acad Sci U S A. 2016;113:13468-73
39. Dufour N, Clermont O, La Combe B, et al. Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex. J Antimicrob Chemother. 2016;71:3072-80
40. van den Dobbelsteen GP, Faé KC, Serroyen J, et al. Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models. Vaccine. 2016;34:4152-60
41. Peirano G, Bradford PA, Kazmierczak KM, et al. Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis. 2014;20:1928-31
42. Ewers C, Göttig S, Bülte M, et al. Genome sequence of avian Escherichia coli strain IHIT25637, an extraintestinal pathogenic E. coli strain of ST131 encoding colistin resistance determinant MCR-1. Genome Announc. 2016;4:e00863-16